Global Tuberculosis Vaccine Drug Market Growth 2026-2032
The global Tuberculosis Vaccine Drug market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?Tuberculosis Vaccine Drug Industry Forecast? looks at past sales and reviews total world Tuberculosis Vaccine Drug sales in 2025, providing a comprehensive analysis by region and market sector of projected Tuberculosis Vaccine Drug sales for 2026 through 2032. With Tuberculosis Vaccine Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tuberculosis Vaccine Drug industry.
This Insight Report provides a comprehensive analysis of the global Tuberculosis Vaccine Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tuberculosis Vaccine Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Tuberculosis Vaccine Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tuberculosis Vaccine Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tuberculosis Vaccine Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Tuberculosis Vaccine Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?Tuberculosis Vaccine Drug Industry Forecast? looks at past sales and reviews total world Tuberculosis Vaccine Drug sales in 2025, providing a comprehensive analysis by region and market sector of projected Tuberculosis Vaccine Drug sales for 2026 through 2032. With Tuberculosis Vaccine Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tuberculosis Vaccine Drug industry.
This Insight Report provides a comprehensive analysis of the global Tuberculosis Vaccine Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tuberculosis Vaccine Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Tuberculosis Vaccine Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tuberculosis Vaccine Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tuberculosis Vaccine Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Tuberculosis Vaccine Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Immune Vaccine
- Therapy Vaccine
- Self-Procurement
- UNICEF
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck
- Japan BCG Lab
- Serum Institute of India
- AJ Vaccines
- BioFarma
- GreenSignal Bio Pharma
- China National Biotec
- Biomed Lublin
- Taj Pharmaceuticals
- Ataulpho de Paiva
- IVAC
- Queen Saovabha Mem. Inst
- Microgen
- What is the 10-year outlook for the global Tuberculosis Vaccine Drug market?
- What factors are driving Tuberculosis Vaccine Drug market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Tuberculosis Vaccine Drug market opportunities vary by end market size?
- How does Tuberculosis Vaccine Drug break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Tuberculosis Vaccine Drug Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Tuberculosis Vaccine Drug by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Tuberculosis Vaccine Drug by Country/Region, 2021, 2025 & 2032
2.2 Tuberculosis Vaccine Drug Segment by Type
2.2.1 Immune Vaccine
2.2.2 Therapy Vaccine
2.2.3 Tuberculosis Vaccine Drug Sales by Type
2.2.3.1 Global Tuberculosis Vaccine Drug Sales Market Share by Type (2021-2026)
2.2.3.2 Global Tuberculosis Vaccine Drug Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Tuberculosis Vaccine Drug Sale Price by Type (2021-2026)
2.3 Tuberculosis Vaccine Drug Segment by Application
2.3.1 Self-Procurement
2.3.2 UNICEF
2.3.3 Other
2.3.4 Tuberculosis Vaccine Drug Sales by Application
2.3.4.1 Global Tuberculosis Vaccine Drug Sale Market Share by Application (2021-2026)
2.3.4.2 Global Tuberculosis Vaccine Drug Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Tuberculosis Vaccine Drug Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Tuberculosis Vaccine Drug Breakdown Data by Company
3.1.1 Global Tuberculosis Vaccine Drug Annual Sales by Company (2021-2026)
3.1.2 Global Tuberculosis Vaccine Drug Sales Market Share by Company (2021-2026)
3.2 Global Tuberculosis Vaccine Drug Annual Revenue by Company (2021-2026)
3.2.1 Global Tuberculosis Vaccine Drug Revenue by Company (2021-2026)
3.2.2 Global Tuberculosis Vaccine Drug Revenue Market Share by Company (2021-2026)
3.3 Global Tuberculosis Vaccine Drug Sale Price by Company
3.4 Key Manufacturers Tuberculosis Vaccine Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Tuberculosis Vaccine Drug Product Location Distribution
3.4.2 Players Tuberculosis Vaccine Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR TUBERCULOSIS VACCINE DRUG BY GEOGRAPHIC REGION
4.1 World Historic Tuberculosis Vaccine Drug Market Size by Geographic Region (2021-2026)
4.1.1 Global Tuberculosis Vaccine Drug Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Tuberculosis Vaccine Drug Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Tuberculosis Vaccine Drug Market Size by Country/Region (2021-2026)
4.2.1 Global Tuberculosis Vaccine Drug Annual Sales by Country/Region (2021-2026)
4.2.2 Global Tuberculosis Vaccine Drug Annual Revenue by Country/Region (2021-2026)
4.3 Americas Tuberculosis Vaccine Drug Sales Growth
4.4 APAC Tuberculosis Vaccine Drug Sales Growth
4.5 Europe Tuberculosis Vaccine Drug Sales Growth
4.6 Middle East & Africa Tuberculosis Vaccine Drug Sales Growth
5 AMERICAS
5.1 Americas Tuberculosis Vaccine Drug Sales by Country
5.1.1 Americas Tuberculosis Vaccine Drug Sales by Country (2021-2026)
5.1.2 Americas Tuberculosis Vaccine Drug Revenue by Country (2021-2026)
5.2 Americas Tuberculosis Vaccine Drug Sales by Type (2021-2026)
5.3 Americas Tuberculosis Vaccine Drug Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tuberculosis Vaccine Drug Sales by Region
6.1.1 APAC Tuberculosis Vaccine Drug Sales by Region (2021-2026)
6.1.2 APAC Tuberculosis Vaccine Drug Revenue by Region (2021-2026)
6.2 APAC Tuberculosis Vaccine Drug Sales by Type (2021-2026)
6.3 APAC Tuberculosis Vaccine Drug Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Tuberculosis Vaccine Drug by Country
7.1.1 Europe Tuberculosis Vaccine Drug Sales by Country (2021-2026)
7.1.2 Europe Tuberculosis Vaccine Drug Revenue by Country (2021-2026)
7.2 Europe Tuberculosis Vaccine Drug Sales by Type (2021-2026)
7.3 Europe Tuberculosis Vaccine Drug Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Tuberculosis Vaccine Drug by Country
8.1.1 Middle East & Africa Tuberculosis Vaccine Drug Sales by Country (2021-2026)
8.1.2 Middle East & Africa Tuberculosis Vaccine Drug Revenue by Country (2021-2026)
8.2 Middle East & Africa Tuberculosis Vaccine Drug Sales by Type (2021-2026)
8.3 Middle East & Africa Tuberculosis Vaccine Drug Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Tuberculosis Vaccine Drug
10.3 Manufacturing Process Analysis of Tuberculosis Vaccine Drug
10.4 Industry Chain Structure of Tuberculosis Vaccine Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Tuberculosis Vaccine Drug Distributors
11.3 Tuberculosis Vaccine Drug Customer
12 WORLD FORECAST REVIEW FOR TUBERCULOSIS VACCINE DRUG BY GEOGRAPHIC REGION
12.1 Global Tuberculosis Vaccine Drug Market Size Forecast by Region
12.1.1 Global Tuberculosis Vaccine Drug Forecast by Region (2027-2032)
12.1.2 Global Tuberculosis Vaccine Drug Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Tuberculosis Vaccine Drug Forecast by Type (2027-2032)
12.7 Global Tuberculosis Vaccine Drug Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Tuberculosis Vaccine Drug Product Portfolios and Specifications
13.1.3 Merck Tuberculosis Vaccine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Japan BCG Lab
13.2.1 Japan BCG Lab Company Information
13.2.2 Japan BCG Lab Tuberculosis Vaccine Drug Product Portfolios and Specifications
13.2.3 Japan BCG Lab Tuberculosis Vaccine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Japan BCG Lab Main Business Overview
13.2.5 Japan BCG Lab Latest Developments
13.3 Serum Institute of India
13.3.1 Serum Institute of India Company Information
13.3.2 Serum Institute of India Tuberculosis Vaccine Drug Product Portfolios and Specifications
13.3.3 Serum Institute of India Tuberculosis Vaccine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Serum Institute of India Main Business Overview
13.3.5 Serum Institute of India Latest Developments
13.4 AJ Vaccines
13.4.1 AJ Vaccines Company Information
13.4.2 AJ Vaccines Tuberculosis Vaccine Drug Product Portfolios and Specifications
13.4.3 AJ Vaccines Tuberculosis Vaccine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 AJ Vaccines Main Business Overview
13.4.5 AJ Vaccines Latest Developments
13.5 BioFarma
13.5.1 BioFarma Company Information
13.5.2 BioFarma Tuberculosis Vaccine Drug Product Portfolios and Specifications
13.5.3 BioFarma Tuberculosis Vaccine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 BioFarma Main Business Overview
13.5.5 BioFarma Latest Developments
13.6 GreenSignal Bio Pharma
13.6.1 GreenSignal Bio Pharma Company Information
13.6.2 GreenSignal Bio Pharma Tuberculosis Vaccine Drug Product Portfolios and Specifications
13.6.3 GreenSignal Bio Pharma Tuberculosis Vaccine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 GreenSignal Bio Pharma Main Business Overview
13.6.5 GreenSignal Bio Pharma Latest Developments
13.7 China National Biotec
13.7.1 China National Biotec Company Information
13.7.2 China National Biotec Tuberculosis Vaccine Drug Product Portfolios and Specifications
13.7.3 China National Biotec Tuberculosis Vaccine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 China National Biotec Main Business Overview
13.7.5 China National Biotec Latest Developments
13.8 Biomed Lublin
13.8.1 Biomed Lublin Company Information
13.8.2 Biomed Lublin Tuberculosis Vaccine Drug Product Portfolios and Specifications
13.8.3 Biomed Lublin Tuberculosis Vaccine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Biomed Lublin Main Business Overview
13.8.5 Biomed Lublin Latest Developments
13.9 Taj Pharmaceuticals
13.9.1 Taj Pharmaceuticals Company Information
13.9.2 Taj Pharmaceuticals Tuberculosis Vaccine Drug Product Portfolios and Specifications
13.9.3 Taj Pharmaceuticals Tuberculosis Vaccine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Taj Pharmaceuticals Main Business Overview
13.9.5 Taj Pharmaceuticals Latest Developments
13.10 Ataulpho de Paiva
13.10.1 Ataulpho de Paiva Company Information
13.10.2 Ataulpho de Paiva Tuberculosis Vaccine Drug Product Portfolios and Specifications
13.10.3 Ataulpho de Paiva Tuberculosis Vaccine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Ataulpho de Paiva Main Business Overview
13.10.5 Ataulpho de Paiva Latest Developments
13.11 IVAC
13.11.1 IVAC Company Information
13.11.2 IVAC Tuberculosis Vaccine Drug Product Portfolios and Specifications
13.11.3 IVAC Tuberculosis Vaccine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 IVAC Main Business Overview
13.11.5 IVAC Latest Developments
13.12 Queen Saovabha Mem. Inst
13.12.1 Queen Saovabha Mem. Inst Company Information
13.12.2 Queen Saovabha Mem. Inst Tuberculosis Vaccine Drug Product Portfolios and Specifications
13.12.3 Queen Saovabha Mem. Inst Tuberculosis Vaccine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Queen Saovabha Mem. Inst Main Business Overview
13.12.5 Queen Saovabha Mem. Inst Latest Developments
13.13 Microgen
13.13.1 Microgen Company Information
13.13.2 Microgen Tuberculosis Vaccine Drug Product Portfolios and Specifications
13.13.3 Microgen Tuberculosis Vaccine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Microgen Main Business Overview
13.13.5 Microgen Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Tuberculosis Vaccine Drug Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Tuberculosis Vaccine Drug by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Tuberculosis Vaccine Drug by Country/Region, 2021, 2025 & 2032
2.2 Tuberculosis Vaccine Drug Segment by Type
2.2.1 Immune Vaccine
2.2.2 Therapy Vaccine
2.2.3 Tuberculosis Vaccine Drug Sales by Type
2.2.3.1 Global Tuberculosis Vaccine Drug Sales Market Share by Type (2021-2026)
2.2.3.2 Global Tuberculosis Vaccine Drug Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Tuberculosis Vaccine Drug Sale Price by Type (2021-2026)
2.3 Tuberculosis Vaccine Drug Segment by Application
2.3.1 Self-Procurement
2.3.2 UNICEF
2.3.3 Other
2.3.4 Tuberculosis Vaccine Drug Sales by Application
2.3.4.1 Global Tuberculosis Vaccine Drug Sale Market Share by Application (2021-2026)
2.3.4.2 Global Tuberculosis Vaccine Drug Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Tuberculosis Vaccine Drug Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Tuberculosis Vaccine Drug Breakdown Data by Company
3.1.1 Global Tuberculosis Vaccine Drug Annual Sales by Company (2021-2026)
3.1.2 Global Tuberculosis Vaccine Drug Sales Market Share by Company (2021-2026)
3.2 Global Tuberculosis Vaccine Drug Annual Revenue by Company (2021-2026)
3.2.1 Global Tuberculosis Vaccine Drug Revenue by Company (2021-2026)
3.2.2 Global Tuberculosis Vaccine Drug Revenue Market Share by Company (2021-2026)
3.3 Global Tuberculosis Vaccine Drug Sale Price by Company
3.4 Key Manufacturers Tuberculosis Vaccine Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Tuberculosis Vaccine Drug Product Location Distribution
3.4.2 Players Tuberculosis Vaccine Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR TUBERCULOSIS VACCINE DRUG BY GEOGRAPHIC REGION
4.1 World Historic Tuberculosis Vaccine Drug Market Size by Geographic Region (2021-2026)
4.1.1 Global Tuberculosis Vaccine Drug Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Tuberculosis Vaccine Drug Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Tuberculosis Vaccine Drug Market Size by Country/Region (2021-2026)
4.2.1 Global Tuberculosis Vaccine Drug Annual Sales by Country/Region (2021-2026)
4.2.2 Global Tuberculosis Vaccine Drug Annual Revenue by Country/Region (2021-2026)
4.3 Americas Tuberculosis Vaccine Drug Sales Growth
4.4 APAC Tuberculosis Vaccine Drug Sales Growth
4.5 Europe Tuberculosis Vaccine Drug Sales Growth
4.6 Middle East & Africa Tuberculosis Vaccine Drug Sales Growth
5 AMERICAS
5.1 Americas Tuberculosis Vaccine Drug Sales by Country
5.1.1 Americas Tuberculosis Vaccine Drug Sales by Country (2021-2026)
5.1.2 Americas Tuberculosis Vaccine Drug Revenue by Country (2021-2026)
5.2 Americas Tuberculosis Vaccine Drug Sales by Type (2021-2026)
5.3 Americas Tuberculosis Vaccine Drug Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tuberculosis Vaccine Drug Sales by Region
6.1.1 APAC Tuberculosis Vaccine Drug Sales by Region (2021-2026)
6.1.2 APAC Tuberculosis Vaccine Drug Revenue by Region (2021-2026)
6.2 APAC Tuberculosis Vaccine Drug Sales by Type (2021-2026)
6.3 APAC Tuberculosis Vaccine Drug Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Tuberculosis Vaccine Drug by Country
7.1.1 Europe Tuberculosis Vaccine Drug Sales by Country (2021-2026)
7.1.2 Europe Tuberculosis Vaccine Drug Revenue by Country (2021-2026)
7.2 Europe Tuberculosis Vaccine Drug Sales by Type (2021-2026)
7.3 Europe Tuberculosis Vaccine Drug Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Tuberculosis Vaccine Drug by Country
8.1.1 Middle East & Africa Tuberculosis Vaccine Drug Sales by Country (2021-2026)
8.1.2 Middle East & Africa Tuberculosis Vaccine Drug Revenue by Country (2021-2026)
8.2 Middle East & Africa Tuberculosis Vaccine Drug Sales by Type (2021-2026)
8.3 Middle East & Africa Tuberculosis Vaccine Drug Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Tuberculosis Vaccine Drug
10.3 Manufacturing Process Analysis of Tuberculosis Vaccine Drug
10.4 Industry Chain Structure of Tuberculosis Vaccine Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Tuberculosis Vaccine Drug Distributors
11.3 Tuberculosis Vaccine Drug Customer
12 WORLD FORECAST REVIEW FOR TUBERCULOSIS VACCINE DRUG BY GEOGRAPHIC REGION
12.1 Global Tuberculosis Vaccine Drug Market Size Forecast by Region
12.1.1 Global Tuberculosis Vaccine Drug Forecast by Region (2027-2032)
12.1.2 Global Tuberculosis Vaccine Drug Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Tuberculosis Vaccine Drug Forecast by Type (2027-2032)
12.7 Global Tuberculosis Vaccine Drug Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Tuberculosis Vaccine Drug Product Portfolios and Specifications
13.1.3 Merck Tuberculosis Vaccine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Japan BCG Lab
13.2.1 Japan BCG Lab Company Information
13.2.2 Japan BCG Lab Tuberculosis Vaccine Drug Product Portfolios and Specifications
13.2.3 Japan BCG Lab Tuberculosis Vaccine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Japan BCG Lab Main Business Overview
13.2.5 Japan BCG Lab Latest Developments
13.3 Serum Institute of India
13.3.1 Serum Institute of India Company Information
13.3.2 Serum Institute of India Tuberculosis Vaccine Drug Product Portfolios and Specifications
13.3.3 Serum Institute of India Tuberculosis Vaccine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Serum Institute of India Main Business Overview
13.3.5 Serum Institute of India Latest Developments
13.4 AJ Vaccines
13.4.1 AJ Vaccines Company Information
13.4.2 AJ Vaccines Tuberculosis Vaccine Drug Product Portfolios and Specifications
13.4.3 AJ Vaccines Tuberculosis Vaccine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 AJ Vaccines Main Business Overview
13.4.5 AJ Vaccines Latest Developments
13.5 BioFarma
13.5.1 BioFarma Company Information
13.5.2 BioFarma Tuberculosis Vaccine Drug Product Portfolios and Specifications
13.5.3 BioFarma Tuberculosis Vaccine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 BioFarma Main Business Overview
13.5.5 BioFarma Latest Developments
13.6 GreenSignal Bio Pharma
13.6.1 GreenSignal Bio Pharma Company Information
13.6.2 GreenSignal Bio Pharma Tuberculosis Vaccine Drug Product Portfolios and Specifications
13.6.3 GreenSignal Bio Pharma Tuberculosis Vaccine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 GreenSignal Bio Pharma Main Business Overview
13.6.5 GreenSignal Bio Pharma Latest Developments
13.7 China National Biotec
13.7.1 China National Biotec Company Information
13.7.2 China National Biotec Tuberculosis Vaccine Drug Product Portfolios and Specifications
13.7.3 China National Biotec Tuberculosis Vaccine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 China National Biotec Main Business Overview
13.7.5 China National Biotec Latest Developments
13.8 Biomed Lublin
13.8.1 Biomed Lublin Company Information
13.8.2 Biomed Lublin Tuberculosis Vaccine Drug Product Portfolios and Specifications
13.8.3 Biomed Lublin Tuberculosis Vaccine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Biomed Lublin Main Business Overview
13.8.5 Biomed Lublin Latest Developments
13.9 Taj Pharmaceuticals
13.9.1 Taj Pharmaceuticals Company Information
13.9.2 Taj Pharmaceuticals Tuberculosis Vaccine Drug Product Portfolios and Specifications
13.9.3 Taj Pharmaceuticals Tuberculosis Vaccine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Taj Pharmaceuticals Main Business Overview
13.9.5 Taj Pharmaceuticals Latest Developments
13.10 Ataulpho de Paiva
13.10.1 Ataulpho de Paiva Company Information
13.10.2 Ataulpho de Paiva Tuberculosis Vaccine Drug Product Portfolios and Specifications
13.10.3 Ataulpho de Paiva Tuberculosis Vaccine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Ataulpho de Paiva Main Business Overview
13.10.5 Ataulpho de Paiva Latest Developments
13.11 IVAC
13.11.1 IVAC Company Information
13.11.2 IVAC Tuberculosis Vaccine Drug Product Portfolios and Specifications
13.11.3 IVAC Tuberculosis Vaccine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 IVAC Main Business Overview
13.11.5 IVAC Latest Developments
13.12 Queen Saovabha Mem. Inst
13.12.1 Queen Saovabha Mem. Inst Company Information
13.12.2 Queen Saovabha Mem. Inst Tuberculosis Vaccine Drug Product Portfolios and Specifications
13.12.3 Queen Saovabha Mem. Inst Tuberculosis Vaccine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Queen Saovabha Mem. Inst Main Business Overview
13.12.5 Queen Saovabha Mem. Inst Latest Developments
13.13 Microgen
13.13.1 Microgen Company Information
13.13.2 Microgen Tuberculosis Vaccine Drug Product Portfolios and Specifications
13.13.3 Microgen Tuberculosis Vaccine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Microgen Main Business Overview
13.13.5 Microgen Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Tuberculosis Vaccine Drug Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Tuberculosis Vaccine Drug Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Immune Vaccine
Table 4. Major Players of Therapy Vaccine
Table 5. Global Tuberculosis Vaccine Drug Sales by Type (2021-2026) & (K Units)
Table 6. Global Tuberculosis Vaccine Drug Sales Market Share by Type (2021-2026)
Table 7. Global Tuberculosis Vaccine Drug Revenue by Type (2021-2026) & ($ million)
Table 8. Global Tuberculosis Vaccine Drug Revenue Market Share by Type (2021-2026)
Table 9. Global Tuberculosis Vaccine Drug Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Tuberculosis Vaccine Drug Sale by Application (2021-2026) & (K Units)
Table 11. Global Tuberculosis Vaccine Drug Sale Market Share by Application (2021-2026)
Table 12. Global Tuberculosis Vaccine Drug Revenue by Application (2021-2026) & ($ million)
Table 13. Global Tuberculosis Vaccine Drug Revenue Market Share by Application (2021-2026)
Table 14. Global Tuberculosis Vaccine Drug Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Tuberculosis Vaccine Drug Sales by Company (2021-2026) & (K Units)
Table 16. Global Tuberculosis Vaccine Drug Sales Market Share by Company (2021-2026)
Table 17. Global Tuberculosis Vaccine Drug Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Tuberculosis Vaccine Drug Revenue Market Share by Company (2021-2026)
Table 19. Global Tuberculosis Vaccine Drug Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Tuberculosis Vaccine Drug Producing Area Distribution and Sales Area
Table 21. Players Tuberculosis Vaccine Drug Products Offered
Table 22. Tuberculosis Vaccine Drug Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Tuberculosis Vaccine Drug Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Tuberculosis Vaccine Drug Sales Market Share Geographic Region (2021-2026)
Table 27. Global Tuberculosis Vaccine Drug Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Tuberculosis Vaccine Drug Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Tuberculosis Vaccine Drug Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Tuberculosis Vaccine Drug Sales Market Share by Country/Region (2021-2026)
Table 31. Global Tuberculosis Vaccine Drug Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Tuberculosis Vaccine Drug Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Tuberculosis Vaccine Drug Sales by Country (2021-2026) & (K Units)
Table 34. Americas Tuberculosis Vaccine Drug Sales Market Share by Country (2021-2026)
Table 35. Americas Tuberculosis Vaccine Drug Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Tuberculosis Vaccine Drug Sales by Type (2021-2026) & (K Units)
Table 37. Americas Tuberculosis Vaccine Drug Sales by Application (2021-2026) & (K Units)
Table 38. APAC Tuberculosis Vaccine Drug Sales by Region (2021-2026) & (K Units)
Table 39. APAC Tuberculosis Vaccine Drug Sales Market Share by Region (2021-2026)
Table 40. APAC Tuberculosis Vaccine Drug Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Tuberculosis Vaccine Drug Sales by Type (2021-2026) & (K Units)
Table 42. APAC Tuberculosis Vaccine Drug Sales by Application (2021-2026) & (K Units)
Table 43. Europe Tuberculosis Vaccine Drug Sales by Country (2021-2026) & (K Units)
Table 44. Europe Tuberculosis Vaccine Drug Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Tuberculosis Vaccine Drug Sales by Type (2021-2026) & (K Units)
Table 46. Europe Tuberculosis Vaccine Drug Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Tuberculosis Vaccine Drug Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Tuberculosis Vaccine Drug Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Tuberculosis Vaccine Drug Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Tuberculosis Vaccine Drug Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Tuberculosis Vaccine Drug
Table 52. Key Market Challenges & Risks of Tuberculosis Vaccine Drug
Table 53. Key Industry Trends of Tuberculosis Vaccine Drug
Table 54. Tuberculosis Vaccine Drug Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Tuberculosis Vaccine Drug Distributors List
Table 57. Tuberculosis Vaccine Drug Customer List
Table 58. Global Tuberculosis Vaccine Drug Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Tuberculosis Vaccine Drug Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Tuberculosis Vaccine Drug Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Tuberculosis Vaccine Drug Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Tuberculosis Vaccine Drug Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Tuberculosis Vaccine Drug Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Tuberculosis Vaccine Drug Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Tuberculosis Vaccine Drug Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Tuberculosis Vaccine Drug Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Tuberculosis Vaccine Drug Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Tuberculosis Vaccine Drug Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Tuberculosis Vaccine Drug Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Tuberculosis Vaccine Drug Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Tuberculosis Vaccine Drug Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Merck Basic Information, Tuberculosis Vaccine Drug Manufacturing Base, Sales Area and Its Competitors
Table 73. Merck Tuberculosis Vaccine Drug Product Portfolios and Specifications
Table 74. Merck Tuberculosis Vaccine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Merck Main Business
Table 76. Merck Latest Developments
Table 77. Japan BCG Lab Basic Information, Tuberculosis Vaccine Drug Manufacturing Base, Sales Area and Its Competitors
Table 78. Japan BCG Lab Tuberculosis Vaccine Drug Product Portfolios and Specifications
Table 79. Japan BCG Lab Tuberculosis Vaccine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Japan BCG Lab Main Business
Table 81. Japan BCG Lab Latest Developments
Table 82. Serum Institute of India Basic Information, Tuberculosis Vaccine Drug Manufacturing Base, Sales Area and Its Competitors
Table 83. Serum Institute of India Tuberculosis Vaccine Drug Product Portfolios and Specifications
Table 84. Serum Institute of India Tuberculosis Vaccine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Serum Institute of India Main Business
Table 86. Serum Institute of India Latest Developments
Table 87. AJ Vaccines Basic Information, Tuberculosis Vaccine Drug Manufacturing Base, Sales Area and Its Competitors
Table 88. AJ Vaccines Tuberculosis Vaccine Drug Product Portfolios and Specifications
Table 89. AJ Vaccines Tuberculosis Vaccine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. AJ Vaccines Main Business
Table 91. AJ Vaccines Latest Developments
Table 92. BioFarma Basic Information, Tuberculosis Vaccine Drug Manufacturing Base, Sales Area and Its Competitors
Table 93. BioFarma Tuberculosis Vaccine Drug Product Portfolios and Specifications
Table 94. BioFarma Tuberculosis Vaccine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. BioFarma Main Business
Table 96. BioFarma Latest Developments
Table 97. GreenSignal Bio Pharma Basic Information, Tuberculosis Vaccine Drug Manufacturing Base, Sales Area and Its Competitors
Table 98. GreenSignal Bio Pharma Tuberculosis Vaccine Drug Product Portfolios and Specifications
Table 99. GreenSignal Bio Pharma Tuberculosis Vaccine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. GreenSignal Bio Pharma Main Business
Table 101. GreenSignal Bio Pharma Latest Developments
Table 102. China National Biotec Basic Information, Tuberculosis Vaccine Drug Manufacturing Base, Sales Area and Its Competitors
Table 103. China National Biotec Tuberculosis Vaccine Drug Product Portfolios and Specifications
Table 104. China National Biotec Tuberculosis Vaccine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. China National Biotec Main Business
Table 106. China National Biotec Latest Developments
Table 107. Biomed Lublin Basic Information, Tuberculosis Vaccine Drug Manufacturing Base, Sales Area and Its Competitors
Table 108. Biomed Lublin Tuberculosis Vaccine Drug Product Portfolios and Specifications
Table 109. Biomed Lublin Tuberculosis Vaccine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Biomed Lublin Main Business
Table 111. Biomed Lublin Latest Developments
Table 112. Taj Pharmaceuticals Basic Information, Tuberculosis Vaccine Drug Manufacturing Base, Sales Area and Its Competitors
Table 113. Taj Pharmaceuticals Tuberculosis Vaccine Drug Product Portfolios and Specifications
Table 114. Taj Pharmaceuticals Tuberculosis Vaccine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Taj Pharmaceuticals Main Business
Table 116. Taj Pharmaceuticals Latest Developments
Table 117. Ataulpho de Paiva Basic Information, Tuberculosis Vaccine Drug Manufacturing Base, Sales Area and Its Competitors
Table 118. Ataulpho de Paiva Tuberculosis Vaccine Drug Product Portfolios and Specifications
Table 119. Ataulpho de Paiva Tuberculosis Vaccine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Ataulpho de Paiva Main Business
Table 121. Ataulpho de Paiva Latest Developments
Table 122. IVAC Basic Information, Tuberculosis Vaccine Drug Manufacturing Base, Sales Area and Its Competitors
Table 123. IVAC Tuberculosis Vaccine Drug Product Portfolios and Specifications
Table 124. IVAC Tuberculosis Vaccine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. IVAC Main Business
Table 126. IVAC Latest Developments
Table 127. Queen Saovabha Mem. Inst Basic Information, Tuberculosis Vaccine Drug Manufacturing Base, Sales Area and Its Competitors
Table 128. Queen Saovabha Mem. Inst Tuberculosis Vaccine Drug Product Portfolios and Specifications
Table 129. Queen Saovabha Mem. Inst Tuberculosis Vaccine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Queen Saovabha Mem. Inst Main Business
Table 131. Queen Saovabha Mem. Inst Latest Developments
Table 132. Microgen Basic Information, Tuberculosis Vaccine Drug Manufacturing Base, Sales Area and Its Competitors
Table 133. Microgen Tuberculosis Vaccine Drug Product Portfolios and Specifications
Table 134. Microgen Tuberculosis Vaccine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Microgen Main Business
Table 136. Microgen Latest Developments
Table 1. Tuberculosis Vaccine Drug Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Tuberculosis Vaccine Drug Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Immune Vaccine
Table 4. Major Players of Therapy Vaccine
Table 5. Global Tuberculosis Vaccine Drug Sales by Type (2021-2026) & (K Units)
Table 6. Global Tuberculosis Vaccine Drug Sales Market Share by Type (2021-2026)
Table 7. Global Tuberculosis Vaccine Drug Revenue by Type (2021-2026) & ($ million)
Table 8. Global Tuberculosis Vaccine Drug Revenue Market Share by Type (2021-2026)
Table 9. Global Tuberculosis Vaccine Drug Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Tuberculosis Vaccine Drug Sale by Application (2021-2026) & (K Units)
Table 11. Global Tuberculosis Vaccine Drug Sale Market Share by Application (2021-2026)
Table 12. Global Tuberculosis Vaccine Drug Revenue by Application (2021-2026) & ($ million)
Table 13. Global Tuberculosis Vaccine Drug Revenue Market Share by Application (2021-2026)
Table 14. Global Tuberculosis Vaccine Drug Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Tuberculosis Vaccine Drug Sales by Company (2021-2026) & (K Units)
Table 16. Global Tuberculosis Vaccine Drug Sales Market Share by Company (2021-2026)
Table 17. Global Tuberculosis Vaccine Drug Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Tuberculosis Vaccine Drug Revenue Market Share by Company (2021-2026)
Table 19. Global Tuberculosis Vaccine Drug Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Tuberculosis Vaccine Drug Producing Area Distribution and Sales Area
Table 21. Players Tuberculosis Vaccine Drug Products Offered
Table 22. Tuberculosis Vaccine Drug Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Tuberculosis Vaccine Drug Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Tuberculosis Vaccine Drug Sales Market Share Geographic Region (2021-2026)
Table 27. Global Tuberculosis Vaccine Drug Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Tuberculosis Vaccine Drug Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Tuberculosis Vaccine Drug Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Tuberculosis Vaccine Drug Sales Market Share by Country/Region (2021-2026)
Table 31. Global Tuberculosis Vaccine Drug Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Tuberculosis Vaccine Drug Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Tuberculosis Vaccine Drug Sales by Country (2021-2026) & (K Units)
Table 34. Americas Tuberculosis Vaccine Drug Sales Market Share by Country (2021-2026)
Table 35. Americas Tuberculosis Vaccine Drug Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Tuberculosis Vaccine Drug Sales by Type (2021-2026) & (K Units)
Table 37. Americas Tuberculosis Vaccine Drug Sales by Application (2021-2026) & (K Units)
Table 38. APAC Tuberculosis Vaccine Drug Sales by Region (2021-2026) & (K Units)
Table 39. APAC Tuberculosis Vaccine Drug Sales Market Share by Region (2021-2026)
Table 40. APAC Tuberculosis Vaccine Drug Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Tuberculosis Vaccine Drug Sales by Type (2021-2026) & (K Units)
Table 42. APAC Tuberculosis Vaccine Drug Sales by Application (2021-2026) & (K Units)
Table 43. Europe Tuberculosis Vaccine Drug Sales by Country (2021-2026) & (K Units)
Table 44. Europe Tuberculosis Vaccine Drug Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Tuberculosis Vaccine Drug Sales by Type (2021-2026) & (K Units)
Table 46. Europe Tuberculosis Vaccine Drug Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Tuberculosis Vaccine Drug Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Tuberculosis Vaccine Drug Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Tuberculosis Vaccine Drug Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Tuberculosis Vaccine Drug Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Tuberculosis Vaccine Drug
Table 52. Key Market Challenges & Risks of Tuberculosis Vaccine Drug
Table 53. Key Industry Trends of Tuberculosis Vaccine Drug
Table 54. Tuberculosis Vaccine Drug Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Tuberculosis Vaccine Drug Distributors List
Table 57. Tuberculosis Vaccine Drug Customer List
Table 58. Global Tuberculosis Vaccine Drug Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Tuberculosis Vaccine Drug Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Tuberculosis Vaccine Drug Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Tuberculosis Vaccine Drug Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Tuberculosis Vaccine Drug Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Tuberculosis Vaccine Drug Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Tuberculosis Vaccine Drug Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Tuberculosis Vaccine Drug Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Tuberculosis Vaccine Drug Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Tuberculosis Vaccine Drug Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Tuberculosis Vaccine Drug Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Tuberculosis Vaccine Drug Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Tuberculosis Vaccine Drug Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Tuberculosis Vaccine Drug Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Merck Basic Information, Tuberculosis Vaccine Drug Manufacturing Base, Sales Area and Its Competitors
Table 73. Merck Tuberculosis Vaccine Drug Product Portfolios and Specifications
Table 74. Merck Tuberculosis Vaccine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Merck Main Business
Table 76. Merck Latest Developments
Table 77. Japan BCG Lab Basic Information, Tuberculosis Vaccine Drug Manufacturing Base, Sales Area and Its Competitors
Table 78. Japan BCG Lab Tuberculosis Vaccine Drug Product Portfolios and Specifications
Table 79. Japan BCG Lab Tuberculosis Vaccine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Japan BCG Lab Main Business
Table 81. Japan BCG Lab Latest Developments
Table 82. Serum Institute of India Basic Information, Tuberculosis Vaccine Drug Manufacturing Base, Sales Area and Its Competitors
Table 83. Serum Institute of India Tuberculosis Vaccine Drug Product Portfolios and Specifications
Table 84. Serum Institute of India Tuberculosis Vaccine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Serum Institute of India Main Business
Table 86. Serum Institute of India Latest Developments
Table 87. AJ Vaccines Basic Information, Tuberculosis Vaccine Drug Manufacturing Base, Sales Area and Its Competitors
Table 88. AJ Vaccines Tuberculosis Vaccine Drug Product Portfolios and Specifications
Table 89. AJ Vaccines Tuberculosis Vaccine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. AJ Vaccines Main Business
Table 91. AJ Vaccines Latest Developments
Table 92. BioFarma Basic Information, Tuberculosis Vaccine Drug Manufacturing Base, Sales Area and Its Competitors
Table 93. BioFarma Tuberculosis Vaccine Drug Product Portfolios and Specifications
Table 94. BioFarma Tuberculosis Vaccine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. BioFarma Main Business
Table 96. BioFarma Latest Developments
Table 97. GreenSignal Bio Pharma Basic Information, Tuberculosis Vaccine Drug Manufacturing Base, Sales Area and Its Competitors
Table 98. GreenSignal Bio Pharma Tuberculosis Vaccine Drug Product Portfolios and Specifications
Table 99. GreenSignal Bio Pharma Tuberculosis Vaccine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. GreenSignal Bio Pharma Main Business
Table 101. GreenSignal Bio Pharma Latest Developments
Table 102. China National Biotec Basic Information, Tuberculosis Vaccine Drug Manufacturing Base, Sales Area and Its Competitors
Table 103. China National Biotec Tuberculosis Vaccine Drug Product Portfolios and Specifications
Table 104. China National Biotec Tuberculosis Vaccine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. China National Biotec Main Business
Table 106. China National Biotec Latest Developments
Table 107. Biomed Lublin Basic Information, Tuberculosis Vaccine Drug Manufacturing Base, Sales Area and Its Competitors
Table 108. Biomed Lublin Tuberculosis Vaccine Drug Product Portfolios and Specifications
Table 109. Biomed Lublin Tuberculosis Vaccine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Biomed Lublin Main Business
Table 111. Biomed Lublin Latest Developments
Table 112. Taj Pharmaceuticals Basic Information, Tuberculosis Vaccine Drug Manufacturing Base, Sales Area and Its Competitors
Table 113. Taj Pharmaceuticals Tuberculosis Vaccine Drug Product Portfolios and Specifications
Table 114. Taj Pharmaceuticals Tuberculosis Vaccine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Taj Pharmaceuticals Main Business
Table 116. Taj Pharmaceuticals Latest Developments
Table 117. Ataulpho de Paiva Basic Information, Tuberculosis Vaccine Drug Manufacturing Base, Sales Area and Its Competitors
Table 118. Ataulpho de Paiva Tuberculosis Vaccine Drug Product Portfolios and Specifications
Table 119. Ataulpho de Paiva Tuberculosis Vaccine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Ataulpho de Paiva Main Business
Table 121. Ataulpho de Paiva Latest Developments
Table 122. IVAC Basic Information, Tuberculosis Vaccine Drug Manufacturing Base, Sales Area and Its Competitors
Table 123. IVAC Tuberculosis Vaccine Drug Product Portfolios and Specifications
Table 124. IVAC Tuberculosis Vaccine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. IVAC Main Business
Table 126. IVAC Latest Developments
Table 127. Queen Saovabha Mem. Inst Basic Information, Tuberculosis Vaccine Drug Manufacturing Base, Sales Area and Its Competitors
Table 128. Queen Saovabha Mem. Inst Tuberculosis Vaccine Drug Product Portfolios and Specifications
Table 129. Queen Saovabha Mem. Inst Tuberculosis Vaccine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Queen Saovabha Mem. Inst Main Business
Table 131. Queen Saovabha Mem. Inst Latest Developments
Table 132. Microgen Basic Information, Tuberculosis Vaccine Drug Manufacturing Base, Sales Area and Its Competitors
Table 133. Microgen Tuberculosis Vaccine Drug Product Portfolios and Specifications
Table 134. Microgen Tuberculosis Vaccine Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Microgen Main Business
Table 136. Microgen Latest Developments
LIST OF FIGURES
Figure 1. Picture of Tuberculosis Vaccine Drug
Figure 2. Tuberculosis Vaccine Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Tuberculosis Vaccine Drug Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Tuberculosis Vaccine Drug Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Tuberculosis Vaccine Drug Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Tuberculosis Vaccine Drug Sales Market Share by Country/Region (2025)
Figure 10. Tuberculosis Vaccine Drug Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Immune Vaccine
Figure 12. Product Picture of Therapy Vaccine
Figure 13. Global Tuberculosis Vaccine Drug Sales Market Share by Type in 2026
Figure 14. Global Tuberculosis Vaccine Drug Revenue Market Share by Type (2021-2026)
Figure 15. Tuberculosis Vaccine Drug Consumed in Self-Procurement
Figure 16. Global Tuberculosis Vaccine Drug Market: Self-Procurement (2021-2026) & (K Units)
Figure 17. Tuberculosis Vaccine Drug Consumed in UNICEF
Figure 18. Global Tuberculosis Vaccine Drug Market: UNICEF (2021-2026) & (K Units)
Figure 19. Tuberculosis Vaccine Drug Consumed in Other
Figure 20. Global Tuberculosis Vaccine Drug Market: Other (2021-2026) & (K Units)
Figure 21. Global Tuberculosis Vaccine Drug Sale Market Share by Application (2025)
Figure 22. Global Tuberculosis Vaccine Drug Revenue Market Share by Application in 2026
Figure 23. Tuberculosis Vaccine Drug Sales by Company in 2026 (K Units)
Figure 24. Global Tuberculosis Vaccine Drug Sales Market Share by Company in 2026
Figure 25. Tuberculosis Vaccine Drug Revenue by Company in 2026 ($ millions)
Figure 26. Global Tuberculosis Vaccine Drug Revenue Market Share by Company in 2026
Figure 27. Global Tuberculosis Vaccine Drug Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Tuberculosis Vaccine Drug Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Tuberculosis Vaccine Drug Sales 2021-2026 (K Units)
Figure 30. Americas Tuberculosis Vaccine Drug Revenue 2021-2026 ($ millions)
Figure 31. APAC Tuberculosis Vaccine Drug Sales 2021-2026 (K Units)
Figure 32. APAC Tuberculosis Vaccine Drug Revenue 2021-2026 ($ millions)
Figure 33. Europe Tuberculosis Vaccine Drug Sales 2021-2026 (K Units)
Figure 34. Europe Tuberculosis Vaccine Drug Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Tuberculosis Vaccine Drug Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Tuberculosis Vaccine Drug Revenue 2021-2026 ($ millions)
Figure 37. Americas Tuberculosis Vaccine Drug Sales Market Share by Country in 2026
Figure 38. Americas Tuberculosis Vaccine Drug Revenue Market Share by Country (2021-2026)
Figure 39. Americas Tuberculosis Vaccine Drug Sales Market Share by Type (2021-2026)
Figure 40. Americas Tuberculosis Vaccine Drug Sales Market Share by Application (2021-2026)
Figure 41. United States Tuberculosis Vaccine Drug Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Tuberculosis Vaccine Drug Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Tuberculosis Vaccine Drug Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Tuberculosis Vaccine Drug Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Tuberculosis Vaccine Drug Sales Market Share by Region in 2026
Figure 46. APAC Tuberculosis Vaccine Drug Revenue Market Share by Region (2021-2026)
Figure 47. APAC Tuberculosis Vaccine Drug Sales Market Share by Type (2021-2026)
Figure 48. APAC Tuberculosis Vaccine Drug Sales Market Share by Application (2021-2026)
Figure 49. China Tuberculosis Vaccine Drug Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Tuberculosis Vaccine Drug Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Tuberculosis Vaccine Drug Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Tuberculosis Vaccine Drug Revenue Growth 2021-2026 ($ millions)
Figure 53. India Tuberculosis Vaccine Drug Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Tuberculosis Vaccine Drug Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Tuberculosis Vaccine Drug Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Tuberculosis Vaccine Drug Sales Market Share by Country in 2026
Figure 57. Europe Tuberculosis Vaccine Drug Revenue Market Share by Country (2021-2026)
Figure 58. Europe Tuberculosis Vaccine Drug Sales Market Share by Type (2021-2026)
Figure 59. Europe Tuberculosis Vaccine Drug Sales Market Share by Application (2021-2026)
Figure 60. Germany Tuberculosis Vaccine Drug Revenue Growth 2021-2026 ($ millions)
Figure 61. France Tuberculosis Vaccine Drug Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Tuberculosis Vaccine Drug Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Tuberculosis Vaccine Drug Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Tuberculosis Vaccine Drug Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Tuberculosis Vaccine Drug Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Tuberculosis Vaccine Drug Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Tuberculosis Vaccine Drug Sales Market Share by Application (2021-2026)
Figure 68. Egypt Tuberculosis Vaccine Drug Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Tuberculosis Vaccine Drug Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Tuberculosis Vaccine Drug Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Tuberculosis Vaccine Drug Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Tuberculosis Vaccine Drug Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Tuberculosis Vaccine Drug in 2026
Figure 74. Manufacturing Process Analysis of Tuberculosis Vaccine Drug
Figure 75. Industry Chain Structure of Tuberculosis Vaccine Drug
Figure 76. Channels of Distribution
Figure 77. Global Tuberculosis Vaccine Drug Sales Market Forecast by Region (2027-2032)
Figure 78. Global Tuberculosis Vaccine Drug Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Tuberculosis Vaccine Drug Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Tuberculosis Vaccine Drug Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Tuberculosis Vaccine Drug Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Tuberculosis Vaccine Drug Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Tuberculosis Vaccine Drug
Figure 2. Tuberculosis Vaccine Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Tuberculosis Vaccine Drug Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Tuberculosis Vaccine Drug Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Tuberculosis Vaccine Drug Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Tuberculosis Vaccine Drug Sales Market Share by Country/Region (2025)
Figure 10. Tuberculosis Vaccine Drug Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Immune Vaccine
Figure 12. Product Picture of Therapy Vaccine
Figure 13. Global Tuberculosis Vaccine Drug Sales Market Share by Type in 2026
Figure 14. Global Tuberculosis Vaccine Drug Revenue Market Share by Type (2021-2026)
Figure 15. Tuberculosis Vaccine Drug Consumed in Self-Procurement
Figure 16. Global Tuberculosis Vaccine Drug Market: Self-Procurement (2021-2026) & (K Units)
Figure 17. Tuberculosis Vaccine Drug Consumed in UNICEF
Figure 18. Global Tuberculosis Vaccine Drug Market: UNICEF (2021-2026) & (K Units)
Figure 19. Tuberculosis Vaccine Drug Consumed in Other
Figure 20. Global Tuberculosis Vaccine Drug Market: Other (2021-2026) & (K Units)
Figure 21. Global Tuberculosis Vaccine Drug Sale Market Share by Application (2025)
Figure 22. Global Tuberculosis Vaccine Drug Revenue Market Share by Application in 2026
Figure 23. Tuberculosis Vaccine Drug Sales by Company in 2026 (K Units)
Figure 24. Global Tuberculosis Vaccine Drug Sales Market Share by Company in 2026
Figure 25. Tuberculosis Vaccine Drug Revenue by Company in 2026 ($ millions)
Figure 26. Global Tuberculosis Vaccine Drug Revenue Market Share by Company in 2026
Figure 27. Global Tuberculosis Vaccine Drug Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Tuberculosis Vaccine Drug Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Tuberculosis Vaccine Drug Sales 2021-2026 (K Units)
Figure 30. Americas Tuberculosis Vaccine Drug Revenue 2021-2026 ($ millions)
Figure 31. APAC Tuberculosis Vaccine Drug Sales 2021-2026 (K Units)
Figure 32. APAC Tuberculosis Vaccine Drug Revenue 2021-2026 ($ millions)
Figure 33. Europe Tuberculosis Vaccine Drug Sales 2021-2026 (K Units)
Figure 34. Europe Tuberculosis Vaccine Drug Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Tuberculosis Vaccine Drug Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Tuberculosis Vaccine Drug Revenue 2021-2026 ($ millions)
Figure 37. Americas Tuberculosis Vaccine Drug Sales Market Share by Country in 2026
Figure 38. Americas Tuberculosis Vaccine Drug Revenue Market Share by Country (2021-2026)
Figure 39. Americas Tuberculosis Vaccine Drug Sales Market Share by Type (2021-2026)
Figure 40. Americas Tuberculosis Vaccine Drug Sales Market Share by Application (2021-2026)
Figure 41. United States Tuberculosis Vaccine Drug Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Tuberculosis Vaccine Drug Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Tuberculosis Vaccine Drug Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Tuberculosis Vaccine Drug Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Tuberculosis Vaccine Drug Sales Market Share by Region in 2026
Figure 46. APAC Tuberculosis Vaccine Drug Revenue Market Share by Region (2021-2026)
Figure 47. APAC Tuberculosis Vaccine Drug Sales Market Share by Type (2021-2026)
Figure 48. APAC Tuberculosis Vaccine Drug Sales Market Share by Application (2021-2026)
Figure 49. China Tuberculosis Vaccine Drug Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Tuberculosis Vaccine Drug Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Tuberculosis Vaccine Drug Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Tuberculosis Vaccine Drug Revenue Growth 2021-2026 ($ millions)
Figure 53. India Tuberculosis Vaccine Drug Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Tuberculosis Vaccine Drug Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Tuberculosis Vaccine Drug Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Tuberculosis Vaccine Drug Sales Market Share by Country in 2026
Figure 57. Europe Tuberculosis Vaccine Drug Revenue Market Share by Country (2021-2026)
Figure 58. Europe Tuberculosis Vaccine Drug Sales Market Share by Type (2021-2026)
Figure 59. Europe Tuberculosis Vaccine Drug Sales Market Share by Application (2021-2026)
Figure 60. Germany Tuberculosis Vaccine Drug Revenue Growth 2021-2026 ($ millions)
Figure 61. France Tuberculosis Vaccine Drug Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Tuberculosis Vaccine Drug Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Tuberculosis Vaccine Drug Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Tuberculosis Vaccine Drug Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Tuberculosis Vaccine Drug Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Tuberculosis Vaccine Drug Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Tuberculosis Vaccine Drug Sales Market Share by Application (2021-2026)
Figure 68. Egypt Tuberculosis Vaccine Drug Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Tuberculosis Vaccine Drug Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Tuberculosis Vaccine Drug Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Tuberculosis Vaccine Drug Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Tuberculosis Vaccine Drug Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Tuberculosis Vaccine Drug in 2026
Figure 74. Manufacturing Process Analysis of Tuberculosis Vaccine Drug
Figure 75. Industry Chain Structure of Tuberculosis Vaccine Drug
Figure 76. Channels of Distribution
Figure 77. Global Tuberculosis Vaccine Drug Sales Market Forecast by Region (2027-2032)
Figure 78. Global Tuberculosis Vaccine Drug Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Tuberculosis Vaccine Drug Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Tuberculosis Vaccine Drug Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Tuberculosis Vaccine Drug Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Tuberculosis Vaccine Drug Revenue Market Share Forecast by Application (2027-2032)
